Karin A. Pacheco
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Karin A. Pacheco has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
Cecile S. Rose
Department of Medicine, Division of Environmental and Occupational Health Sciences, National Jewish Health, Denver, CO
3 shared publicationsAndrew H. Liu
Department of Pediatrics, National Jewish Medical and Research Center Denver CO, USA
2 shared publications- James Crooks
National Jewish Health
2 shared publications Kelly Goelz
Department of Medicine, Division of Environmental and Occupational Health Sciences, National Jewish Health, Denver, CO
2 shared publicationsLee S. Newman
Department of Medicine, National Jewish Medical and Research Center Denver CO, USA 3 Department of Medicine, University of Colorado School of Medicine Denver CO, USA
2 shared publicationsLisa A. Maier
Chief, Division of Environmental & Occupational Health Sciences, Professor of Medicine, Department of Medicine, National Jewish Health, 1400 Jackson St. Denver, CO 80206; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, School of Medicine, Department of Environmental/Occupational Health, Colorado School of Public Health, University of Colorado Denver, 13001 E 17th Place, Mail Stop B119, Aurora, CO 80045
2 shared publications
Latest Publications
- 19 June 2025
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 25 (1) , 1-11
Updates in Metal Allergy: A Review of New Pathways of Sensitization, Exposure, and Treatment
Purpose of Review Metal exposures are widespread, and ensuing allergic sensitization leads to secondary disease processes, especially contact dermatitis, with chronic implications. This review covers recently described mechanisms of sensitization, sources of exposure, and treatment options. Recent Findings Sensitization to metals is similar to other allergic processes: it is triggered by innate responses, which then facilitate allergic priming. Early oral exposures may lead to tolerance, whereas initial cutaneous exposures by piercings start the pathway toward sensitization. Nickel ‘allergy’ may be ubiquitous because of multiple pathways of immune response. Although the most frequent reaction to metals is a type IV immune response, some metals, including platinum and sometimes nickel, can also trigger a type I IgE mediated response. Current treatment involves avoidance of exposure and suppression of the response, although inducing tolerance by early oral exposure may be the best method to avoid disease. Summary Better understanding of the factors and contacts that drive metal sensitization will enable better management of the types and timing of exposure, which then may instead induce tolerance and prevent disease.
- 19 June 2025
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 25 (1) , 1-11
Updates in Metal Allergy: A Review of New Pathways of Sensitization, Exposure, and Treatment
Purpose of Review Metal exposures are widespread, and ensuing allergic sensitization leads to secondary disease processes, especially contact dermatitis, with chronic implications. This review covers recently described mechanisms of sensitization, sources of exposure, and treatment options. Recent Findings Sensitization to metals is similar to other allergic processes: it is triggered by innate responses, which then facilitate allergic priming. Early oral exposures may lead to tolerance, whereas initial cutaneous exposures by piercings start the pathway toward sensitization. Nickel ‘allergy’ may be ubiquitous because of multiple pathways of immune response. Although the most frequent reaction to metals is a type IV immune response, some metals, including platinum and sometimes nickel, can also trigger a type I IgE mediated response. Current treatment involves avoidance of exposure and suppression of the response, although inducing tolerance by early oral exposure may be the best method to avoid disease. Summary Better understanding of the factors and contacts that drive metal sensitization will enable better management of the types and timing of exposure, which then may instead induce tolerance and prevent disease.
- 25 November 2024
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 68 (1) , 68-75
Sarcoidosis in Beryllium Exposed Workers: A Case‐Case Study
Background: Despite the utility of the beryllium lymphocyte proliferation test (BeLPT), distinguishing sarcoidosis, a disease of unknown etiology, from chronic beryllium disease (CBD), has long posed a diagnostic challenge. It is unclear if beryllium‐exposed sarcoidosis cases (Be‐exp‐Sarc) are clinically distinct from CBD, or are misdiagnosed cases of CBD.Methods: We performed a case‐case study of 40 beryllium‐exposed individuals diagnosed with Be‐exp‐Sarc compared to 40 frequency‐matched CBD cases. We compared demographics, exposure, clinical, physical, and radiographic characteristics and HLA DBPI E69 genotype.Results: Compared to CBD, Be‐exp‐Sarc cases were diagnosed at a younger age, had lower lung function, were less likely to have normal radiographic imaging, were more likely to have massive adenopathy and extra‐thoracic manifestations and were more likely to have been prescribed systemic immunosuppressive therapy. Be‐exp‐Sarc tended to have fewer years of beryllium exposure, but there were no significant differences in the amount of beryllium exposure. HLA DPBI E69 was present in 53% of Be‐exp‐Sarc cases, not different from the general population, versus 92% of CBD cases (p < 0.001).Conclusions: While a number of differences were observed, the only absolute distinguishing features were lack of confirmed beryllium sensitization in Be‐exp‐Sarc and lack of extra‐thoracic manifestations in CBD. These findings suggest that Be‐exp‐Sarc may be distinct from CBD, and beryllium or some other workplace exposure may possibly play an as yet to be defined etiologic role, although the possibility that these cases could be due to selection bias from heightened surveillance in beryllium workforces cannot be excluded.
- 25 November 2024
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 68 (1) , 68-75
Sarcoidosis in Beryllium Exposed Workers: A Case‐Case Study
Background: Despite the utility of the beryllium lymphocyte proliferation test (BeLPT), distinguishing sarcoidosis, a disease of unknown etiology, from chronic beryllium disease (CBD), has long posed a diagnostic challenge. It is unclear if beryllium‐exposed sarcoidosis cases (Be‐exp‐Sarc) are clinically distinct from CBD, or are misdiagnosed cases of CBD.Methods: We performed a case‐case study of 40 beryllium‐exposed individuals diagnosed with Be‐exp‐Sarc compared to 40 frequency‐matched CBD cases. We compared demographics, exposure, clinical, physical, and radiographic characteristics and HLA DBPI E69 genotype.Results: Compared to CBD, Be‐exp‐Sarc cases were diagnosed at a younger age, had lower lung function, were less likely to have normal radiographic imaging, were more likely to have massive adenopathy and extra‐thoracic manifestations and were more likely to have been prescribed systemic immunosuppressive therapy. Be‐exp‐Sarc tended to have fewer years of beryllium exposure, but there were no significant differences in the amount of beryllium exposure. HLA DPBI E69 was present in 53% of Be‐exp‐Sarc cases, not different from the general population, versus 92% of CBD cases (p < 0.001).Conclusions: While a number of differences were observed, the only absolute distinguishing features were lack of confirmed beryllium sensitization in Be‐exp‐Sarc and lack of extra‐thoracic manifestations in CBD. These findings suggest that Be‐exp‐Sarc may be distinct from CBD, and beryllium or some other workplace exposure may possibly play an as yet to be defined etiologic role, although the possibility that these cases could be due to selection bias from heightened surveillance in beryllium workforces cannot be excluded.
- Open Access
- 14 September 2024
- Published by Wiley
Synovial fluid nickel and cobalt concentrations in patients with failed cobalt/chromium knee replacements
Background : Cobalt/chromium alloy is the most frequently used material in knee replacement hardware. It is composed of 60% cobalt, 30% chromium, 5% molybdenum, and contains from 0.5 - 2% nickel. We have found that nickel sensitization is an important cause of failed knee replacements in these patients. Despite such low percent concentrations in the alloy, whether nickel elutes from the implant material and become detectable in synovial fluid from cobalt/chromium knee replacements has never been measured. If so, such soluble material would be more available to trigger an immune inflammatory response. Methods : After obtaining written informed consent, we collected synovial fluid from the knees of patients with failed cobalt/chromium knee replacements, from those with other non-nickel containing implants, or those without implants with osteoarthritis or rheumatoid arthritis. We measured synovial fluid concentrations of nickel, cobalt, chromium, and molybdenum by inductively coupled plasma-mass spectrometry (ICP-MS). Results : Nickel and cobalt concentrations were significantly higher in patients with cobalt/chromium knee replacements, and virtually non-detectable in other non-nickel, non-cobalt implants or in other causes of knee arthritis. In those with failed cobalt/chromium knee hardware, nickel concentrations were also significantly higher in patients with failure due to nickel sensitization compared to those with other causes of failure. Conclusion : Despite low concentrations in cobalt/chromium alloy, nickel does elute from this material, is detectable in synovial fluid from failed cobalt/chromium knee replacements, and is significantly higher in nickel-sensitized patients with these failed implants. Elevated cobalt concentrations are also found in some of these patients.
- 14 September 2024
- Published by Wiley
Open AccessSynovial fluid nickel and cobalt concentrations in patients with failed cobalt/chromium knee replacements
Background : Cobalt/chromium alloy is the most frequently used material in knee replacement hardware. It is composed of 60% cobalt, 30% chromium, 5% molybdenum, and contains from 0.5 - 2% nickel. We have found that nickel sensitization is an important cause of failed knee replacements in these patients. Despite such low percent concentrations in the alloy, whether nickel elutes from the implant material and become detectable in synovial fluid from cobalt/chromium knee replacements has never been measured. If so, such soluble material would be more available to trigger an immune inflammatory response. Methods : After obtaining written informed consent, we collected synovial fluid from the knees of patients with failed cobalt/chromium knee replacements, from those with other non-nickel containing implants, or those without implants with osteoarthritis or rheumatoid arthritis. We measured synovial fluid concentrations of nickel, cobalt, chromium, and molybdenum by inductively coupled plasma-mass spectrometry (ICP-MS). Results : Nickel and cobalt concentrations were significantly higher in patients with cobalt/chromium knee replacements, and virtually non-detectable in other non-nickel, non-cobalt implants or in other causes of knee arthritis. In those with failed cobalt/chromium knee hardware, nickel concentrations were also significantly higher in patients with failure due to nickel sensitization compared to those with other causes of failure. Conclusion : Despite low concentrations in cobalt/chromium alloy, nickel does elute from this material, is detectable in synovial fluid from failed cobalt/chromium knee replacements, and is significantly higher in nickel-sensitized patients with these failed implants. Elevated cobalt concentrations are also found in some of these patients.
- 26 July 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (9) , 2280-2295
Contact Dermatitis From Biomedical Devices, Implants, and Metals—Trouble From Within
- 26 July 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (9) , 2280-2295
Contact Dermatitis From Biomedical Devices, Implants, and Metals—Trouble From Within
- Open Access
- 16 May 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (8) , 1951-1958
How Allergists Can Perform an Occupational History in Every Patient
- 16 May 2024
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 12 (8) , 1951-1958
Open AccessHow Allergists Can Perform an Occupational History in Every Patient
- 7 November 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 11 (11) , 3414-3416
Treatment of Work-Related Asthma: More Severe, Less Adherent, and Still Working
- 7 November 2023
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 11 (11) , 3414-3416
Treatment of Work-Related Asthma: More Severe, Less Adherent, and Still Working
- Open Access
- 28 October 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (21) , 5027
Synovial Fluid Cytokines, Chemokines and MMP Levels in Osteoarthritis Patients with Knee Pain Display a Profile Similar to Many Rheumatoid Arthritis Patients
Background: There are currently no effective disease-modifying drugs to prevent cartilage loss in osteoarthritis and synovial fluid is a potentially valuable source of biomarkers to understand the pathogenesis of different types of arthritis and identify drug responsiveness. The aim of this study was to compare the differences between SF cytokines and other proteins in patients with OA (n = 21) to those with RA (n = 27) and normal knees (n = 3). Methods: SF was obtained using ultrasound (US) guidance and an external pneumatic compression device. RA patients were categorized as active (n = 20) or controlled (n = 7) based upon SF white blood cell counts (> or 3). Samples were cryopreserved and analyzed by multiplex fluorescent bead assays (Luminex). Between-group differences of 16 separate biomarker proteins were identified using ANOVA on log10-transformed concentrations with p values adjusted for multiple testing. Results: Only six biomarkers were significantly higher in SF from active RA compared to OA—TNF-α, IL-1-β IL-7, MMP-1, MMP-2, and MMP-3. Only MMP-8 levels in RA patients correlated with SF WBC counts (p < 0.0001). Among OA patients, simultaneous SF IL-4, IL-6, IL-8, and IL-15 levels were higher than serum levels, whereas MMP-8, MMP-9, and IL-18 levels were higher in serum (p < 0.05). Conclusion: These results support the growing evidence that OA patients have a pro-inflammatory/catabolic SF environment. SF biomarker analysis using multiplex testing and US guidance may distinguish OA phenotypes and identify treatment options based upon targeted inflammatory pathways similar to patients with RA.
- 28 October 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (21) , 5027
Open AccessSynovial Fluid Cytokines, Chemokines and MMP Levels in Osteoarthritis Patients with Knee Pain Display a Profile Similar to Many Rheumatoid Arthritis Patients
Background: There are currently no effective disease-modifying drugs to prevent cartilage loss in osteoarthritis and synovial fluid is a potentially valuable source of biomarkers to understand the pathogenesis of different types of arthritis and identify drug responsiveness. The aim of this study was to compare the differences between SF cytokines and other proteins in patients with OA (n = 21) to those with RA (n = 27) and normal knees (n = 3). Methods: SF was obtained using ultrasound (US) guidance and an external pneumatic compression device. RA patients were categorized as active (n = 20) or controlled (n = 7) based upon SF white blood cell counts (> or 3). Samples were cryopreserved and analyzed by multiplex fluorescent bead assays (Luminex). Between-group differences of 16 separate biomarker proteins were identified using ANOVA on log10-transformed concentrations with p values adjusted for multiple testing. Results: Only six biomarkers were significantly higher in SF from active RA compared to OA—TNF-α, IL-1-β IL-7, MMP-1, MMP-2, and MMP-3. Only MMP-8 levels in RA patients correlated with SF WBC counts (p < 0.0001). Among OA patients, simultaneous SF IL-4, IL-6, IL-8, and IL-15 levels were higher than serum levels, whereas MMP-8, MMP-9, and IL-18 levels were higher in serum (p < 0.05). Conclusion: These results support the growing evidence that OA patients have a pro-inflammatory/catabolic SF environment. SF biomarker analysis using multiplex testing and US guidance may distinguish OA phenotypes and identify treatment options based upon targeted inflammatory pathways similar to patients with RA.
- 1 August 2021
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 9 (8) , 3109-3117.e1
Sensitization to Implant Components Is Associated with Joint Replacement Failure: Identification and Revision to Nonallergenic Hardware Improves Outcomes
- 1 August 2021
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 9 (8) , 3109-3117.e1
Sensitization to Implant Components Is Associated with Joint Replacement Failure: Identification and Revision to Nonallergenic Hardware Improves Outcomes
- Open Access
- 28 February 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (5) , 2428
The T Cell Repertoires from Nickel Sensitized Joint Implant Failure Patients
Nickel (Ni2+) is one of the most common allergens, affecting around 10–15% of the general population. As the demand for orthopedic implant surgery rises, the number of surgical revisions due to joint implant failure also increases. There is evidence that some patients develop joint failure due to an immune response to a component of the implant, and we have found that Ni2+ is an especially important cause. Hence, understanding the mechanisms by which Ni2+ allergy induces joint implant failure becomes a critical research question. The structural basis of Ni2+ activation of pathogenic T cells is still not clear. The purpose of this study was to characterize Ni2+-reactive T cell repertoires derived from the peripheral blood of joint failure patients due to Ni2+ sensitization using single-cell sequencing techniques. We stimulated the proliferation of Ni2+ -reactive T cells from two implant failure patients in vitro, and sorted them for single-cell VDJ sequencing (10× genomics). We identified 2650 productive V-J spanning pairs. Both TCR α chains and β chains were enriched. TRBV18 usage is the highest in the P7 CD4+ population (18.1%), and TRBV5-1 usage is the highest in the P7 CD8+ population (12.1%). TRBV19 and TRBV20-1 segments are present in a high percentage of both P7 and P9 sequenced T cells. Remarkably, the alpha and beta chain combination of TRAV41-TRBV18 accounts for 13.5% of the CD4+ population of P7 patient. Compared to current Ni specific T cell repertoire studies of contact dermatitis, the Vα and Vβ usages of these joint implant failure patients were different. This could be due to the different availability of self-peptides in these two different tissues. However, TRBV19 (Vβ17) was among frequently used TCR β chains, which are common in previous reports. This implies that some pathogenic T cells could be similar in Ni2+ hypersensitivities in skin and joints. The alignment of the TCR CDR3β sequences showed a conserved glutamic acid (Glu) that could potentially interact with Ni2+. The study of these Ni2+ specific TCRs may shed light on the molecular mechanism of T cell activation by low molecular weight chemical haptens.
- 28 February 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (5) , 2428
Open AccessThe T Cell Repertoires from Nickel Sensitized Joint Implant Failure Patients
Nickel (Ni2+) is one of the most common allergens, affecting around 10–15% of the general population. As the demand for orthopedic implant surgery rises, the number of surgical revisions due to joint implant failure also increases. There is evidence that some patients develop joint failure due to an immune response to a component of the implant, and we have found that Ni2+ is an especially important cause. Hence, understanding the mechanisms by which Ni2+ allergy induces joint implant failure becomes a critical research question. The structural basis of Ni2+ activation of pathogenic T cells is still not clear. The purpose of this study was to characterize Ni2+-reactive T cell repertoires derived from the peripheral blood of joint failure patients due to Ni2+ sensitization using single-cell sequencing techniques. We stimulated the proliferation of Ni2+ -reactive T cells from two implant failure patients in vitro, and sorted them for single-cell VDJ sequencing (10× genomics). We identified 2650 productive V-J spanning pairs. Both TCR α chains and β chains were enriched. TRBV18 usage is the highest in the P7 CD4+ population (18.1%), and TRBV5-1 usage is the highest in the P7 CD8+ population (12.1%). TRBV19 and TRBV20-1 segments are present in a high percentage of both P7 and P9 sequenced T cells. Remarkably, the alpha and beta chain combination of TRAV41-TRBV18 accounts for 13.5% of the CD4+ population of P7 patient. Compared to current Ni specific T cell repertoire studies of contact dermatitis, the Vα and Vβ usages of these joint implant failure patients were different. This could be due to the different availability of self-peptides in these two different tissues. However, TRBV19 (Vβ17) was among frequently used TCR β chains, which are common in previous reports. This implies that some pathogenic T cells could be similar in Ni2+ hypersensitivities in skin and joints. The alignment of the TCR CDR3β sequences showed a conserved glutamic acid (Glu) that could potentially interact with Ni2+. The study of these Ni2+ specific TCRs may shed light on the molecular mechanism of T cell activation by low molecular weight chemical haptens.
- 9 June 2020
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 63 (8) , 726-732
Isocyanate induced allergic contact dermatitis in a university undergraduate student: An occupational dermatitis case report, review of laboratory safety regulations, and implications for campus research
A 19‐year‐old female college undergraduate developed an intensely swollen, erythematous and pruritic rash on the face and hands while working in an optical fabrication lab producing photosensitive polymers. She had no respiratory symptoms. The rash was consistent with contact dermatitis and there was no clinical evidence of respiratory involvement with normal spirometry. A review of the safety data sheets of chemicals used in the laboratory revealed several known sensitizers, including 6‐hexamethylene diisocyanate (HDI), dibutyl phthalate, and 2,4,6‐tribromophenyl acrylate. Patch testing confirmed the patient's sensitization to HDI. A subsequent worksite visit identified several hazardous chemicals that were used without appropriate hazard communication, training, standard operating procedures, or personal protective equipment. Simple exposure controls were recommended and instituted, and the patient was able to return to work in the laboratory without the recurrence of symptoms. This case demonstrates the importance of hazard identification, communication, and safety training in academic laboratories, for students and workers. A medical evaluation can identify hazards as well as lead to improvements in exposure controls and safe return to research.
- 9 June 2020
- Published by Wiley in American Journal of Industrial Medicine
- Vol. 63 (8) , 726-732
Isocyanate induced allergic contact dermatitis in a university undergraduate student: An occupational dermatitis case report, review of laboratory safety regulations, and implications for campus research
A 19‐year‐old female college undergraduate developed an intensely swollen, erythematous and pruritic rash on the face and hands while working in an optical fabrication lab producing photosensitive polymers. She had no respiratory symptoms. The rash was consistent with contact dermatitis and there was no clinical evidence of respiratory involvement with normal spirometry. A review of the safety data sheets of chemicals used in the laboratory revealed several known sensitizers, including 6‐hexamethylene diisocyanate (HDI), dibutyl phthalate, and 2,4,6‐tribromophenyl acrylate. Patch testing confirmed the patient's sensitization to HDI. A subsequent worksite visit identified several hazardous chemicals that were used without appropriate hazard communication, training, standard operating procedures, or personal protective equipment. Simple exposure controls were recommended and instituted, and the patient was able to return to work in the laboratory without the recurrence of symptoms. This case demonstrates the importance of hazard identification, communication, and safety training in academic laboratories, for students and workers. A medical evaluation can identify hazards as well as lead to improvements in exposure controls and safe return to research.